Company research
NYMOX PHARMACEUTICAL CORP
CIK 1018735Updated Sep 26, 2026
SecurityNYMXF · OTC · equity
Historical securities (1)
NYMX · NASDAQ · equity · closed Jul 6, 2023NYMXF price & chart
Loading TradingView…
OTC:NYMXF on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2024 · USDSource
Source
cash flow · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Profit or LossUSD | -4,492,000Source | -8,844,000Source | -6,576,000Source | -12,537,000Source |
| Additional Financial Items | ||||
| AdjustmentsForFinanceCostsUSD | — | — | 28,000Source | 20,000Source |
| AdjustmentsForFinanceIncomeUSD | 17,000Source | 7,000Source | 6,000Source | 6,000Source |
| AdjustmentsForIncreaseDecreaseInTradeAccountPayableUSD | 1,243,000Source | 1,322,000Source | 376,000Source | — |
| AdjustmentsForSharebasedPaymentsUSD | 671,000Source | 3,357,000Source | 593,000Source | 2,603,000Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesUSD | 64,000Source | 173,000Source | — | — |
| ProceedsFromBorrowingsClassifiedAsFinancingActivitiesUSD | 2,669,000Source | 1,750,000Source | — | — |
| ProceedsFromIssuingSharesUSD | 0Source | 1,150,000Source | 6,007,000Source | 7,283,000Source |
income statement · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cost of Goods and Services Sold | — | — | — | — |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 1,003,000Source | 4,356,000Source | 2,879,000Source | 5,846,000Source |
| Total RevenueUSD | — | — | 0Source | 0Source |
| Additional Financial Items | ||||
| BasicEarningsLossPerShareUSD per share | -0.05Source | -0.1Source | -0.07Source | -0.15Source |
| FinanceCostsUSD | 226,000Source | 58,000Source | -28,000Source | — |
| FinanceIncomeUSD | 17,000Source | 7,000Source | 6,000Source | 6,000Source |
| IncomeTaxExpenseContinuingOperationsUSD | 0Source | 0Source | — | — |
| OtherIncomeUSD | 0Source | 0Source | 113,000Source | — |
| ProfitLossAttributableToOwnersOfParentUSD | -4,492,000Source | -8,844,000Source | -6,576,000Source | -12,537,000Source |
| ProfitLossBeforeTaxUSD | -4,492,000Source | -8,844,000Source | -6,576,000Source | -33,000Source |
| ProfitLossFromOperatingActivitiesUSD | -4,283,000Source | -8,350,000Source | -6,652,000Source | -12,504,000Source |
| ResearchAndDevelopmentExpenseUSD | 3,280,000Source | 3,994,000Source | 3,773,000Source | 6,658,000Source |
| RevenueFromInterestUSD | 2,000Source | 6,000Source | 1,000Source | 8,000Source |
| TaxRateEffectOfForeignTaxRatesnumber | 0.21Source | 0.21Source | 0.21Source | 0.21Source |